NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/04/2021
Back to search
Official data from USPTO
ZEDI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
06/04/2021
Classification
Registered
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
09/29/2009
Registration date
03/08/2011
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/03/2021
Last transaction
06/03/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
03
Owner location
Darmstadt, DE
Examiner
COOPER,CHRISTINE H
Law office
M40
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of an animal in the nature of a guinea pig or hamster wearing a t-shirt with the wording "ZEDI" on one sleeve.
Holders and representatives
Holders
Zedira GmbH
Zedira GmbH
Representatives
Dwayne K. Goetzel Kowert, Hood, Munyon, Rankin & Goetzel, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical and biochemical productschemicalschemical preparationsbiochemical preparations for industrial or scientific purposes
Class 5
(( Medicines for the treatment of celiac diseasesautoimmune diseasesfood intolerancesintestinal diseasesirritable bowel syndromefibrosisscarringhypertrophic scarssclerodermadiabetic nephropathyhepatic fibrosiscirrhosispulmonary fibrosisatherosclerosiscancerthrombolytic therapyacneskin agingpsoriasisneurodegenerative diseasesAlzheimer's diseaseHuntington's diseasesParkinson's diseasecataractsaffection by microorganismsinfections or candidiasis; pharmaceutical and veterinary medical productspreparations for healthcare for the treatment of celiac diseasesautoimmune diseasesfood intolerancesintestinal diseasesirritable bowel syndromefibrosisscarringhypertrophic scarssclerodermadiabetic nephropathyhepatic fibrosiscirrhosispulmonary fibrosisatherosclerosiscancerthrombolytic therapyacneskin agingpsoriasisneurodegenerative diseasesAlzheimer's diseaseHuntington's diseasesParkinson's diseasecataractsaffection by microorganismsinfections or candidiasis; preparations or pharmaceuticalsfor the treatment and prophylaxis of celiac diseasesautoimmune diseasesfood intolerancesintestinal diseasesirritable bowel syndromefibrosisscarringhypertrophic scarssclerodermadiabetic nephropathyhepatic fibrosiscirrhosispulmonary fibrosisatherosclerosiscancerthrombolytic therapyacneskin agingpsoriasisneurodegenerative diseasesAlzheimer's diseaseHuntington's diseaseParkinson's diseasecataractsbacterial or yeast infectioninfectionscandidiasis; chemical and biochemical productschemical preparations in the nature of chemical reagents and biochemical preparations for medical purposes; chemical and biochemical productschemical preparations in the nature of chemical reagents and biochemical preparations for healthcare; chemical and biochemical productschemical preparations in the nature of chemical reagents and biochemical preparations for human and veterinary medical use; dietetic productsdietary supplementsdietetic foods adapted for medical use; dietetic productsdietary supplementsdietetic foods adapted for healthcare; dietetic productsdietary supplementsdietetic foods adapted for human and veterinary medical use; dietary supplements for medical purposes; disinfectants for medical instrumentsfor hygienic purposesfor sanitary purposes; preparations for destroying vermin; chemical and biochemical products for medical science for use in or on the human or animal bodybiochemical preparations and chemical reagents; diagnostic agent for medical purposes; X-ray contrast agent for medical purposes; germicidal detergents for medical purposes ))
Class 42
Commissioned research in the field of medical researchmedical devices and biological research; conducting research and development work in the medicalpharmaceuticalpharmacologicalbiochemical and/or medicine technological area on behalf of third parties; commissioned execution of clinical trials and clinical studies in the field of medical and scientific research; commissioned assessment of scientific projects in the field of quality assessment and evaluationcommissioned evaluation of clinical trials and studies in the field of quality assessment and evaluation; services of a biochemical laboratory; services of an analytical laboratory in the field of medicalbiological and chemical
Publications
History of USPTO decisions and trademark events.
54 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/03/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/03/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/03/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
02/26/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/08/2020
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/05/2018
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
06/05/2018
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/31/2018
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
04/06/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/06/2018
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
01/19/2017
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
01/19/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/19/2017
E15R
TEAS SECTION 15 RECEIVED
12/15/2016
ES8R
TEAS SECTION 8 RECEIVED
12/15/2016
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/15/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
03/08/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/21/2010
PUBO
PUBLISHED FOR OPPOSITION
12/21/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/15/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/11/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
11/10/2010
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/10/2010
GNEA
EXAMINERS AMENDMENT E-MAILED
11/10/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/10/2010
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/08/2010
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/05/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/26/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/25/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
10/25/2010
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/25/2010
GNEA
EXAMINERS AMENDMENT E-MAILED
10/25/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/25/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/20/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2010
ALIE
ASSIGNED TO LIE
10/18/2010
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/15/2010
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/04/2010
GNFR
FINAL REFUSAL E-MAILED
08/04/2010
CNFR
FINAL REFUSAL WRITTEN
08/04/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/15/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/15/2010
ALIE
ASSIGNED TO LIE
07/15/2010
FAXX
FAX RECEIVED
06/30/2010
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/29/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/29/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/29/2009
GNRT
NON-FINAL ACTION E-MAILED
12/29/2009
CNRT
NON-FINAL ACTION WRITTEN
12/29/2009
DOCK
ASSIGNED TO EXAMINER
12/26/2009
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
10/09/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/08/2009
NWAP
NEW APPLICATION ENTERED
10/02/2009
Continuous trademark protection
Get notified about every new filing that threatens ZEDI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.